Primary mechanisms include: Because of this profile, AOD 9604 is commonly used in in vitro systems and animal models focused on obesity research, adipocyte signaling, metabolic dysfunction, and energy-balance regulation
Bowery Clinic peptides are higher-strength and clinically dosed compared to most research facilities that use much lower concentrations
Research Background AHK-Cu has been investigated in preclinical dermatological research for its effects on dermal papilla cells and hair follicle cycling
+ - 5-Amino-1MQ and NAD+ work synergistically to boost cellular energy, with 5-Amino-1MQ acting as a metabolic "mechanic" that inhibits the NNMT enzyme to prevent waste, while NAD+ acts as the fuel
Its value in a clinical setting comes from what it is not: it does not disrupt appetite, hormones, insulin, or IGF-1